好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Small Fiber Neuropathies: Sensory, Autonomic and Both

Wednesday 04/25/12
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Roy L. Freeman, MD
Participants should be familiar with the pathophysiology, semiology, differential diagnosis, small fiber and autonomic testing, laboratory evaluation, and treatment of small fiber somatic and autonomic neuropathies.
No CME available
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist
Case-based, Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
06:30 AM - 08:30 AM Small Fiber Neuropathies: Sensory, Autonomic and Both
Roy L. Freeman, MD, Giuseppe Lauria, MD
06:30 AM - 08:30 AM Break
Faculty Disclosures
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Giuseppe Lauria, MD No disclosure on file